PSAT1 and Its Role in Colon Cancer Growth and Drug Resistance
Author Information
Author(s): Vié Nadia, Copois Virginie, Bascoul-Mollevi Caroline, Denis Vincent, Bec Nicole, Robert Bruno, Fraslon Caroline, Conseiller Emmanuel, Molina Franck, Larroque Christian, Martineau Pierre, Del Rio Maguy, Gongora Céline
Primary Institution: CNRS, UMR 5160, CRLC, Montpellier, France
Hypothesis
The study aims to investigate the role of phosphoserine aminotransferase PSAT1 in colorectal cancer development.
Conclusion
PSAT1 overexpression is linked to increased cell growth and chemoresistance in colon cancer, suggesting it as a potential therapeutic target.
Supporting Evidence
- PSAT1 is overexpressed in colon tumors.
- Higher PSAT1 levels correlate with poor tumor regression after chemotherapy.
- SW480-PSAT1 cells show increased growth and survival rates.
- SW480-PSAT1 cells are more resistant to oxaliplatin treatment.
Takeaway
This study found that a protein called PSAT1 helps colon cancer cells grow faster and makes them tougher against treatments.
Methodology
The study involved analyzing PSAT1 expression in tumor samples and human cell lines, and assessing the effects of PSAT1 overexpression on cell growth and drug resistance.
Limitations
The study's findings are based on a limited number of clinical samples, which may not be statistically significant.
Participant Demographics
{"gender":{"male":18,"female":11},"age":{"median":60.2,"range":"(45.1: 76.0)"}}
Statistical Information
P-Value
p < 0.0001
Statistical Significance
p < 0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website